China possessing a majority of biotech manufacturing capabilities would not only transfer economic opportunity away from the U.S., it would increase American dependency on China. There is also an ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

This week, medical tech firm Medtronic opted for tapping into China's biotech advancements. On Monday, it launched a digital healthcare innovation base at BioPark in the Beijing Economic ...

The China-based biotech was formed in 2018 by Ascendis Pharma and an investor syndicate led by Vivo Capital. The biotech is designed to develop and commercialize Ascendis’ endocrinology ...

ImmuneOnco Biopharmaceuticals has shown Chinese biotechs are far from immune to the pressures to prioritize pipelines. | ...